The COVID-19 pandemic has resulted in a proliferation of clinical trials
The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ;
The COVID-19 pandemic has resulted in a proliferation of clinical trials that are designed to slow the spread of SARS - CoV-2 , the virus that causes COVID-19 .
The overwhelming majority of cardiovascular and cancer patients are at increased risk for SARS - CoV-2 infection ; accordingly , the cardiovascular and cardio - oncology communities are playing a major role in caring for COVID-19 patients .